Skip to search formSkip to main contentSkip to account menu

Nizoral

Known as: Janssen Brand of Ketoconazole, Ketoconazole Janssen Brand 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Ketoconazole
Ketoconazole 20 MG/ML Medicated Shampoo [Nizoral]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
The validity of self-rated psychotic symptoms in depressed inpatients
2011
2011
Update on a Phase III Study of Panobinostat with Bortezomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: PANORAMA 1,
Abstract 3976 Background: The outcomes of patients with multiple myeloma (MM) have significantly improved in recent years mainly… 
2011
2011
Preliminary Results of a Phase 2 Study of PD 0332991 in Combination with Bortezomib and Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma
Abstract 2940 Background: PD 0332991 is an orally bioavailable selective inhibitor of cyclin-dependent kinase (CDK) 4/6… 
2010
2010
Clinical Outcome According to Both Cytogenetic Abnormalities (CA) Detected by Fluorescence In Situ Hibridization (FISH) and Hyperdiploidy Assessed by Flow Cytometry (FCM) In Elderly Newly Diagnosed…
Abstract 309 Background: Novel insights into the biology of myeloma cells have led to the identification of relevant prognosis… 
2008
2008
Efficacy of Early Treatment with Calcimimetics in Combination with Reduced Doses of Vitamin D Sterols in Dialysis Patients
Vitamin D is an important physiologic regulator of bone and mineral metabolism. In chronic kidney disease, reduced renal… 
2006
2006
In vivo efficacy of an antifungal fraction from Pallavicinia lyellii , a liverwort
Almost all the antifungal agents, currently in use, have toxic side effects and are relatively expensive. Therefore, there is an… 
2005
2005
Comparative study of muromonab-CD3 (OKT3) versus daclizumab (Zenapax) in cardiac transplantation at our center.
Review
2004
Review
2004
A cost-utility analysis of adjunctive treatment with newer antiepileptic drugs in the UK
Summary A recent review found that economic assessment of epilepsy treatment relies largely on hypothetical modelling of outcomes… 
Review
1998
Review
1998
Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia.
Cladribine (Leustatin; Janssen-Cilag, Ortho Biotech Inc, Raritan, NJ) is a novel injectable nucleoside analogue with marked… 
Review
1983
Review
1983
Ketoconazole (Nizoral, Janssen Pharmaceutica, Inc.)
The treatment of most fungal infections is difficult, at best. Antifungal therapy is complicated by the development of resistant… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)